{"nct_id":"NCT06353386","title":"Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-05-20","start_date_type":"ACTUAL","primary_completion_date":"2028-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2028-03-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}